Evaluation of the Medtronic Exponent Self-Expanding Carotid Stent System With the Medtronic Guardwire Temporary Occlusion and Aspiration System in the Treatment of Carotid Stenosis
- 1 February 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 41 (2) , e102-9
Abstract
Background and Purpose— Embolic protection devices and improved stent technology have advanced the endovascular treatment of carotid artery disease. A combined analysis was performed of the MAVErIC ( M edtronic AVE Self-expanding Ca R otid Stent System with distal protection) I and II trials to evaluate the safety and feasibility of this system among patients at high risk for surgical endarterectomy. Methods— Four hundred ninety-eight patients were enrolled in the MAVErIC I (99 patients) and MAVErIC II (399 patients) studies from June 2001 to October 2004. The results were pooled for statistical analysis of a common primary end point, the 365-day rate of major adverse events. Clinical follow-up took place at 30 days, 6 months, and 365 days postprocedure. Results— The 365-day major adverse event rate, defined as death, stroke, or myocardial infarction within 30 days, and death, ipsilateral stroke, or myocardial infarction from days 31 to 365 was 12.5%. The incidence of neurological death through 365 days was 1.1%. The 30-day major adverse event rate was 5.4%. Subgroup analyses showed no notable differences in the 365-day major adverse event rate for symptomatic patients compared with asymptomatic patients. Conclusion— Treatment of carotid artery disease with carotid artery stenting with a self-expanding stent and distal embolic protection results in a low 30-day adverse event rate, including the occurrence of stroke in patients at high risk for carotid endarterectomy.Keywords
This publication has 29 references indexed in Scilit:
- Endarterectomy vs stenting for carotid artery stenosis: A systematic review and meta-analysisJournal of Vascular Surgery, 2008
- Carotid artery revascularization in high surgical risk patients with the NexStent and the Filterwire EX/EZCatheterization and Cardiovascular Interventions, 2008
- Carotid Artery Revascularization in High-Surgical-Risk Patients Using the Carotid WALLSTENT and FilterWire EX/EZJACC, 2008
- Protected Carotid Stenting in High-Risk Patients With Severe Carotid Artery StenosisJACC, 2006
- Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day resultsCatheterization and Cardiovascular Interventions, 2006
- Updated review of the global carotid artery stent registryCatheterization and Cardiovascular Interventions, 2003
- Multicenter clinical trial of the NexStent coiled sheet stent in the treatment of extracranial carotid artery stenosis: immediate results and late clinical outcomesJournal of Neurosurgery, 2003
- Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection DevicesStroke, 2003
- Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trialJournal of Vascular Surgery, 1998
- Carotid Endarterectomy RevisitedJournal of Endovascular Surgery, 1996